Cargando…
Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is an extremely complicated neurodegenerative disorder, which accounts for almost 80 % of all dementia diagnoses. Due to the limited treatment efficacy, it is imperative for AD patients to take reliable prevention and diagnosis measures. This study aimed to explo...
Autores principales: | Wang, Huimin, Han, Xiujiang, Gao, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259215/ https://www.ncbi.nlm.nih.gov/pubmed/34225819 http://dx.doi.org/10.1186/s41065-021-00187-9 |
Ejemplares similares
-
A 2 miRNAs-based signature for the diagnosis of atherosclerosis
por: Han, Xiujiang, et al.
Publicado: (2021) -
Exploring Potential Biomarkers Underlying Pathogenesis of Alzheimer’s Disease by Differential Co-expression Analysis
por: Izadi, Fereshteh, et al.
Publicado: (2018) -
Identification and diagnostic potential of serum microRNAs as biomarkers for early detection of Alzheimer’s disease
por: Han, Ying-Hao, et al.
Publicado: (2023) -
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
por: Shen, Heping, et al.
Publicado: (2021) -
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bai, Bing, et al.
Publicado: (2021)